| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.18 | 0.2 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.19 | 0.5 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.19 | 0.3 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |